Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumption
Sign Up to like & getrecommendations! Published in 2019 at "Neuropsychopharmacology"
DOI: 10.1038/s41386-019-0475-8
Abstract: There is increasing interest in developing drugs that act at α4β2 nicotinic acetylcholine receptors (nAChRs) to treat alcohol use disorder. The smoking cessation agent varenicline, a partial agonist of α4β2 nAChRs, reduces alcohol intake, but… read more here.
Keywords: intake; ethanol consumption; activity nicotinic; consumption ... See more keywords